Validity of Viome's Oral/throat Cancer Test
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorViome
About this trial
A total of at least 1,000 participants with suspicion of cancer including at least 107 subjects who will be diagnosed with OSCC or OPSCC will be enrolled from either primary or secondary care centers in the U.S. Clinicians will use Viome collection kits to collect saliva samples from eligible patients.
Eligibility criteria
Qualifiers
Signed and dated informed consent prior to any study-specific procedures are performed
Willing and able to follow the study instructions, as described in the recruitment letter
Adults (18 years old or older)
Suspicion of OSCC or OPSCC on clinical presentation by a clinician
Disqualifiers
Pregnancy
Use of fertility enhancing medications
Trial design
Treatments tested in this trial
- Oral/Throat cancer test
Treatment groups
1,000 Participants
are divided into 3 treatment groupsLocations
2Missouri School of Dentistry & Oral Health63104, St LouisMissouri, United States
UTHSC38163, MemphisTennessee, United States
Sponsors and collaborators
Viome
Lead sponsor
Source ClinicalTrials.gov